Saturday, December 28, 2024

Carter Towler to assist with Yorkshire Cancer Research’s ambitious expansion

Carter Towler has been appointed by Yorkshire Cancer Research to help the charity fund vital research in Yorkshire through further expansion of its network of shops.

Yorkshire Cancer Research recently started to expand its shop network, and this is already raising hundreds of thousands of pounds to help fund life-saving research in Yorkshire.

The chartered surveyors have been tasked by the charity to find five suitable retail units per year for the next three years.

Commenting on the new instruction, Carter Towler’s Max Vause said: “We first got involved with Yorkshire Cancer Research a couple of months ago when they decided to take over the tenancy of a property we were marketing at The Arcade in Ripon. They explained they were trying to find more similar retail units and asked us to help.

“We are delighted to be working for them; they are the biggest independent regional cancer research charity and have funded hundreds of millions of pounds of research since they were founded in 1925. Our property searches will aim to identify retail premises across Yorkshire. We’re looking for properties that offer high footfall, where there will be high quality stock donations and access to plenty of volunteer staff.”

Tony Graham, head of retail at Harrogate-based Yorkshire Cancer Research, added: “Our shops play a vital role in our fundraising and we are extremely fortunate to have built up a very loyal customer and volunteer base. By having Carter Towler working with us we will be able to scale-up our retail operations quickly and efficiently. By 2025 we are aiming to have 20 outlets.”

Yorkshire Cancer Research is a registered charity that funds pioneering research to prevent, diagnose and treat cancer in Yorkshire. The charity aims to save 2,000 lives from cancer every year in Yorkshire and is committed to funding £10m of research each year to achieve this. The charity funds experts who pioneer early cancer diagnosis and discover new and better treatments for people with cancer.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.








Latest news

Related news